{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:24:26Z","timestamp":1761513866893,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.clbc.2021.07.014","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T12:04:52Z","timestamp":1627387492000},"page":"e263-e269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effective Surveillance of High-Risk Women"],"prefix":"10.1016","volume":"22","author":[{"given":"Margaret","family":"Lotz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musie","family":"Ghebremichael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Chervinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Zorc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Bousvaros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Pories","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2021.07.014_bib0001","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2021.07.014_bib0002","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2021.07.014_bib0003","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/tbj.12354","article-title":"Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs","volume":"21","author":"Tab\u00e1r","year":"2015","journal-title":"Breast J"},{"key":"10.1016\/j.clbc.2021.07.014_bib0004","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/ijc.30794","article-title":"Benefits and harms of breast cancer screening with mammography in women aged 40-49 years: A systematic review","volume":"141","author":"van den Ende","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2021.07.014_bib0005","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.2015.13183","article-title":"Benefits and harms of breast cancer screening: a systematic review","volume":"314","author":"Myers","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2021.07.014_bib0006","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.crad.2017.10.021","article-title":"Clinical role of breast MRI now and going forward","volume":"73","author":"Leithner","year":"2018","journal-title":"Clin Radiol"},{"key":"10.1016\/j.clbc.2021.07.014_bib0007","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa065447","article-title":"MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer","volume":"356","author":"Lehman","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2021.07.014_bib0008","first-page":"75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"10.1016\/j.clbc.2021.07.014_bib0009","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3390\/cancers10120477","article-title":"Screening BRCA1 and BRCA2 mutation carriers for breast cancer","volume":"10","author":"Warner","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clbc.2021.07.014_bib0010","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/jama.2015.12783","article-title":"Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society","volume":"314","author":"Oeffinger","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2021.07.014_bib0011","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2010.28.0784","article-title":"Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia","volume":"28","author":"Boughey","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.07.014_bib0012","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/S0140-6736(11)61350-0","article-title":"MRI for breast cancer screening, diagnosis, and treatment","volume":"378","author":"Morrow","year":"2011","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.clbc.2021.07.014_bib0013","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1245\/s10434-019-07814-w","article-title":"The Tyrer-Cuzick model inaccurately predicts invasive breast cancer risk in women with LCIS","volume":"27","author":"Valero","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.07.014_bib0014","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-017-4247-z","article-title":"Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications","volume":"164","author":"Cintolo-Gonzalez","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.07.014_bib0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1158\/1055-9965.EPI-12-0570","article-title":"Which risk model to use? Clinical implications of the ACS MRI screening guidelines","volume":"22","author":"Ozanne","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"10.1016\/j.clbc.2021.07.014_bib0016","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJMms2004740","article-title":"Hidden in plain sight \u2014 reconsidering the use of race correction in clinical algorithms","volume":"383","author":"Vyas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2021.07.014_bib0017","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.clbc.2021.07.014_bib0018","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1148\/radiol.2019182716","article-title":"A deep learning mammography-based model for improved breast cancer risk prediction","volume":"292","author":"Yala","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2021.07.014_bib0019","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0174","article-title":"Long-term accuracy of breast cancer risk assessment combining classic risk factors and breast density","volume":"4","author":"Brentnall","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2021.07.014_bib0020","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10549-013-2725-5","article-title":"Is there a role for routine screening MRI in women with LCIS?","volume":"142","author":"King","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.07.014_bib0021","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/tbj.13259","article-title":"Screening breast MRI in patients with history of atypia or lobular neoplasia","volume":"25","author":"Chikarmane","year":"2019","journal-title":"Breast J"},{"key":"10.1016\/j.clbc.2021.07.014_bib0022","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/radiol.2017161519","article-title":"National performance benchmarks for modern diagnostic digital mammography: update from the breast cancer surveillance consortium","volume":"283","author":"Sprague","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2021.07.014_bib0023","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1148\/radiol.2017162033","article-title":"Performance benchmarks for screening breast MR imaging in community practice","volume":"285","author":"Lee","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2021.07.014_bib0024","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1067\/j.cpradiol.2013.03.001","article-title":"Controversies in breast MRI","volume":"42","author":"Sutcliffe","year":"2013","journal-title":"Curr Probl Diagn Radiol"},{"key":"10.1016\/j.clbc.2021.07.014_bib0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.amjsurg.2010.09.005","article-title":"Utilization of minimally invasive breast biopsy for the evaluation of suspicious breast lesions","volume":"202","author":"Gutwein","year":"2011","journal-title":"Am J Surg"},{"key":"10.1016\/j.clbc.2021.07.014_bib0026","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/RLI.0000000000000507","article-title":"Dechelation (Transmetalation): consequences and safety concerns with the linear gadolinium-based contrast agents, in view of recent health care rulings by the EMA (Europe), FDA (United States), and PMDA (Japan)","volume":"53","author":"Runge","year":"2018","journal-title":"Invest Radiol"},{"key":"10.1016\/j.clbc.2021.07.014_bib0027","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2214\/AJR.19.21988","article-title":"Gadolinium retention and breast MRI screening: more harm than good?","volume":"214","author":"Sardanelli","year":"2020","journal-title":"AJR Am J Roentgenol."},{"key":"10.1016\/j.clbc.2021.07.014_bib0028","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1474-4422(17)30158-8","article-title":"Gadolinium deposition in the brain: summary of evidence and recommendations","volume":"16","author":"Gulani","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clbc.2021.07.014_bib0029","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1148\/radiol.2019181637","article-title":"Digital 2D versus tomosynthesis screening mammography among women aged 65 and older in the United States","volume":"291","author":"Bahl","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2021.07.014_bib0030","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1200\/JCO.2013.52.8331","article-title":"Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program","volume":"32","author":"Chiarelli","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.07.014_bib0031","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/bjc.2013.632","article-title":"Ethnic differences in breast cancer incidence in England are due to differences in known risk factors for the disease: prospective study","volume":"110","author":"Gathani","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2021.07.014_bib0032","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1245\/s10434-020-08853-4","article-title":"Baseline screening MRI uptake and findings in women with >\/= 20% lifetime risk of breast cancer","volume":"27","author":"Laws","year":"2020","journal-title":"Ann Surg Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820921002007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820921002007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:22:05Z","timestamp":1761513725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820921002007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1526820921002007"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2021.07.014","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective Surveillance of High-Risk Women","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2021.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}